ManulifeMetLife
Live Report · Updated April 27, 2026

Manulife vs MetLife

Manulife operates across North America and Asia with a large wealth and insurance platform while MetLife is a global insurance and employee benefits giant with deep U.S. institutional roots. Both comp...

Why It's Moving

Manulife

MFC Stock Warning: Why Analysts See -46% Downside Risk

  • Elevated PE ratio of 38.8 dwarfs industry peers, signaling overvaluation and potential for sharp correction if growth falters.
  • Earnings and revenue expansion trails sector competitors, raising doubts on Manulife's ability to sustain momentum in a competitive landscape.
  • Heavy reliance on acquisitions, digital pushes, and Asia exposure introduces execution risks, amplified by macro sensitivity to rates and equity volatility.
Sentiment:
🐻Bearish

Investment Analysis

Pros

  • Manulife has demonstrated superior stock performance with a 10% return over the past 12 months, outperforming MetLife.
  • The company maintains a strong return on equity of 16.25%, reflecting efficient use of shareholder capital.
  • It is valued attractively with a price/earnings ratio of 11.30, suggesting reasonable valuation compared to peers.

Considerations

  • Manulife exhibits a relatively low return on assets at 0.75%, indicating potential inefficiencies in asset utilisation.
  • The stock has shown volatility with one-year lows around C$36.93, which may concern more risk-averse investors.
  • Recent insider selling activity could signal reduced confidence from management regarding near-term stock performance.

Pros

  • MetLife is a well-established global insurer with a diversified product portfolio reducing business risk.
  • It benefits from strong operational scale and brand recognition in the insurance industry.
  • The company maintains solid interest coverage, indicating sufficient earnings to service debt obligations.

Considerations

  • MetLife's stock has declined by approximately 2% over the past year, underperforming compared to Manulife.
  • Its return on equity is lower at around 14.43%, showing slightly less efficient capital utilisation than Manulife.
  • Recent stock price movements show increased volatility and a notable intraday price range, potentially signalling market uncertainty.

Manulife (MFC) Next Earnings Date

Manulife Financial (MFC) is expected to report its next earnings on May 5 or May 13, 2026, following its most recent Q4 2025 release on February 11, 2026. This upcoming report will cover Q1 2026 results, typically announced after market close with a conference call the following day. Estimates vary slightly across sources, reflecting historical patterns of early May releases for MFC.

Buy MFC or MET in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

MFC
MFC$42.11
vs
MET
MET$76.63